GLOW Mischung / BPC-157 + Tb4 (TB-500) + GHK-Cu

Beschreibung

Multi-pathway recovery & tissue signaling blend

GLOW is a combination peptide blend formulated with GHK-Cu, BPC-157, and full sequence Thymosin β4 (TB-500), bringing together multiple research pathways involved in tissue signaling, cellular migration, recovery dynamics, and connective tissue investigation.
Rather than focusing on a single mechanism, this blend is designed around complementary peptide interactions frequently explored in regenerative and recovery-related research models. GHK-Cu is widely studied for copper-peptide signaling and skin-related remodeling pathways, BPC-157 for tissue signaling and angiogenesis-related mechanisms, and TB-500 for cellular migration and cytoskeletal dynamics.
Researchers commonly investigate these compounds together in experimental models involving soft tissue response, recovery coordination, inflammatory pathway modulation, and peptide-mediated regenerative signaling. Compared to single-pathway recovery peptides, GLOW represents a broader multi-compound research model within the healing & recovery category.
Contains full-length Thymosin Beta-4 (43 amino acids), not truncated fragment variants known as TB-500. Full-length TB4 (43 amino acids) is structurally distinct from shorter fragments and is studied for its role in actin regulation and cellular repair mechanisms.

Research applications (investigational)

GLOW has been investigated in preclinical and experimental settings for its involvement in:

• Tissue signaling and peptide-mediated recovery pathways
• Angiogenesis and microvascular response mechanisms
• Cellular migration and cytoskeletal dynamics
• Skin remodeling and extracellular matrix research
• Connective tissue and soft tissue recovery models
• Inflammatory signaling pathway interaction
• Multi-peptide regenerative pathway analysis

These areas reflect ongoing scientific investigation into peptide-mediated recovery and tissue signaling rather than established applications.

Product characteristics

Purity: ≥ 98% (HPLC)
Appearance: light blue lyophilized powder (due to GHK-Cu content)
Composition: 50 mg GHK-Cu + 10 mg BPC-157 + 10 mg Tb4 per vial
Molecular formula (GHK-Cu): C₁₄H₂₂CuN₆O₄
Molecular formula (BPC-157): C₆₂H₉₈N₁₆O₂₂
Molecular formula Thymosin Beta-4 (full sequence): C₂₁₄H₃₅₃O₇₉N₅₇S₁
Storage: store lyophilized powder at -20°C, protect from light and moisture. Reconstituted solution should be kept at 2–8°C and used within a short period.

Why choose our GLOW blend

High-purity research-grade peptide components.
Produced in GMP-compliant facilities under strict QC protocols.
Each batch carefully lab tested after production (you can find Certificate of Analysis under product pictures). Each peptide component is individually batch-tested prior to blending.
Combination designed for broad recovery and tissue signaling research models.
Freeze-dried (lyophilized) for maximum stability and extended shelf life.
Sealed in sterile vials, ready for reconstitution.
Reconstitution: reconstitute gently with bacteriostatic water. Multi-peptide blends may require slow swirling and additional time for complete dissolution.

Selected research references

• GHK-Cu
  Pickart L et al. The human tri-peptide GHK and tissue remodeling research. Journal of Biomaterials Science, 2015.
• Abdulghani S et al. Copper peptide signaling and skin remodeling pathways. International Journal of Molecular Sciences, 2023.
  BPC-157
• Sikiric P et al. Stable gastric pentadecapeptide BPC 157 in wound healing and tissue research. Current Pharmaceutical Design, 2010.
• Vukojević J et al. BPC 157 and nitric oxide system interactions. Nitric Oxide, 2018.
  TB-500 / Thymosin β4
• Goldstein AL et al. Thymosin β4 and tissue repair mechanisms. Annals of the New York Academy of Sciences, 2007.
• Malinda KM et al. Thymosin beta4 accelerates wound healing. Journal of Investigative Dermatology, 1999.

Related research context

GLOW belongs to the Healing & recovery peptide research category, combining compounds frequently studied for complementary regenerative signaling pathways.
Researchers exploring multi-pathway recovery models may also examine:

BPC-157 — tissue signaling and angiogenesis research
Thymosin β4 (TB-500) — migration and cytoskeletal signaling
GHK-Cu — copper peptide and extracellular remodeling pathways
Wolverine (BPC-157 + TB-500) — dual-pathway recovery blend

For broader context, see the Healing & recovery research guide.

NOTE: This is for educational reference only and does not constitute medical advice.

Disclaimer
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.